Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Taylor, J. C.
Right arrow Articles by Lanham, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, J. C.
Right arrow Articles by Lanham, J.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 901-902
© 2003 British Society for Rheumatology

Letters to the Editor

Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy

J. C. Taylor, R. Orkin and J. Lanham

Department of Rheumatology, Whipps Cross University Hospital, Whipps Cross Road, London E11 1NR, UK

The first 10% of the full text of this article appears below.

SIR, The increased risk of tuberculosis (TB) in patients receiving anti-tumour necrosis factor (TNF) therapy is of great concern. A recent case of ours raises a further worry that patients on anti-TNF may be particularly refractory to treatment. Our patient was a 65-yr-old man, born in Calcutta and resident in the UK for over 30 yr, with seropositive erosive rheumatoid arthritis . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
J. Keane
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic
Rheumatology, June 1, 2005; 44(6): 714 - 720.
[Abstract] [Full Text] [PDF]